Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors

Breast Cancer Research and Treatment

Volumn 106, Issue 2, 2007, Pages 161-170

  Eisner, Alvin ^a   Toomey, Maureen D ^a   Falardeau, Julie ^a   Samples, John R ^a   Vetto, John T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adjuvant endocrine therapy; Anastrozole; Breast cancer; Eye; Optic cup; Optic nerve head; Tamoxifen

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

ADULT; AGED; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTIC DISK CUP; OPTIC NERVE; POSTMENOPAUSE; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

ADULT; AGED; AMENORRHEA; AROMATASE INHIBITORS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LASERS; MIDDLE AGED; NITRILES; OPHTHALMOSCOPY; OPTIC DISK; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SURVIVAL RATE; SURVIVORS; TAMOXIFEN; TRIAZOLES; VISUAL ACUITY;

EID: 35748971775     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9486-3     Document Type: Article

References (51)

1. Wolff AC, Davidson NE (2001) Use of SERMs for the adjuvant therapy of early-stage breast cancer. Ann N Y Acad Sci 949:80-88
2. Colozza M, de Azambuja E, Cardoso F et al (2006) Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era. Oncologist 11:111-125
3. Tredway DR, Buraglio M, Hemsey G et al (2004) A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers. Fertil Steril 82:1587-1593
4. Clemons M, Coleman RE, Verma S (2004) Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard? Cancer Treat Rev 30:325-332
5. Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86:225-230
6. Baum M (2005) Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now? Eur J Cancer 41:1667-1677
7. Howell A (2005) New developments in the treatment of postmenopausal breast cancer. Trends Endocrinol Metab 16:420-428
8. Nabholtz JM (2006) Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention. Oncology 70:1-12
9. Nayfield SG, Gorin MB (1996) Tamoxifen-associated eye disease. A review. J Clin Oncol 14:1018-1026
10. Gorin MB, Day R, Costantino JP et al (1998) Long-term tamoxifen citrate use and potential ocular toxicity. Am J Ophthalmol 125:493-501
11. Tang R, Shields J, Schiffman J et al (1997) Retinal changes associated with tamoxifen treatment for breast cancer. Eye 11(Pt 3):295-297
12. Eisner A, O'Malley JP, Incognito LJ et al (2006) Small optic cup sizes among women using tamoxifen: assessment with scanning laser ophthalmoscopy. Curr Eye Res 31:367-379
13. Sardini A, Amey JS, Weylandt KH et al (2003) Cell volume regulation and swelling-activated chloride channels. Biochim Biophys Acta 1618:153-162
14. Jentsch TJ, Stein V, Weinreich F et al (2002) Molecular structure and physiological function of chloride channels. Physiol Rev 82:503-568
15. Darby M, Kuzmiski JB, Panenka W et al (2003) ATP released from astrocytes during swelling activates chloride channels. J Neurophysiol 89:1870-1877
16. Kimelberg HK (2005) Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50:389-397
17. Bussow H (1980) The astrocytes in the retina and optic nerve head of mammals: a special glia for the ganglion cell axons. Cell Tissue Res 206:367-378
18. Hernandez MR (2000) The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 19:297-321
19. Eisner A, Incognito LJ (2006) The color appearance of stimuli detected via short-wavelength-sensitive cones for breast cancer survivors using tamoxifen. Vision Res 46:1816-1822
20. Eisner A, Austin DF, Samples JR (2004) Short wavelength automated perimetry and tamoxifen use. Br J Ophthalmol 88:125-130
21. Morales L, Neven P, Timmerman D et al (2004) Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs 15:753-760
22. Loprinzi CL, Zahasky KM, Sloan JA et al (2000) Tamoxifen-induced hot flashes. Clin Breast Cancer 1:52-56
23. Eisner A, Samples JR (2003) High blood pressure and visual sensitivity. J Opt Soc Am A Opt Image Sci Vis 20:1681-1693
24. Mourits MJ, De Vries EG, Willemse PH et al (2001) Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 97:855-866
25. McKinlay SM, Brambilla DJ, Posner JG (1992) The normal menopause transition. Maturitas 14:103-115
26. Fingaret M, Flanagan JG, Liebmann JM (2005) The essential HRT primer. Jacoto Advertising Inc., San Ramon, CA
27. Burgoyne CF, Downs JC, Bellezza AJ et al (2004) Three-dimensional reconstruction of normal and early glaucoma monkey optic nerve head connective tissues. Invest Ophthalmol Vis Sci 45:4388-4399
28. http://www.heidelbergengineering.com. search FAQ
29. Saruhan A, Orgul S, Kocak I et al (1998) Descriptive information of topographic parameters computed at the optic nerve head with the Heidelberg Retina Tomograph. J Glaucoma 7:420-429
30. Ludbrook J (1998) Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25:1032-1037
31. Manquez ME, Brown MM, Shields CL et al (2006) Management of choroidal metastases from breast carcinomas using aromatase inhibitors. Curr Opin Ophthalmol 17:251-256
32. Gallicchio L, Lord G, Tkaczuk K et al (2004) Association of tamoxifen (TAM) and TAM metabolite concentrations with self-reported side effects of TAM in women with breast cancer. Breast Cancer Res Treat 85:89-97
33. Noureddin BN, Seoud M, Bashshur Z et al (1999) Ocular toxicity in low-dose tamoxifen: a prospective study. Eye 13(Pt 6):729-733
34. Colley SM, Elston JS (2004) Tamoxifen optic neuropathy. Clin Exp Ophthalmol 32:105-106
35. Therssen R, Jansen E, Leys A et al (1995) Screening for tamoxifen ocular toxicity: a prospective study. Eur J Ophthalmol 5:230-234
36. Pugesgaard T, Von Eyben FE (1986) Bilateral optic neuritis evolved during tamoxifen treatment. Cancer 58:383-386
37. Ashford AR, Donev I, Tiwari RP et al (1988) Reversible ocular toxicity related to tamoxifen therapy. Cancer 61:33-35
38. Fraunfelder FT, Fraunfelder FW (2001) Drug-induced ocular side effects. Butterworth-Heinemann, Boston, pp 471-474
39. Burgoyne CF (2004) Image analysis of optic nerve disease. Eye 18:1207-1213
40. Kimelberg HK (2004) Increased release of excitatory amino acids by the actions of ATP and peroxynitrite on volume-regulated anion channels (VRACs) in astrocytes. Neurochem Int 45:511-519
41. Minckler DS, McLean IW, Tso MO (1976) Distribution of axonal and glial elements in the rhesus optic nerve head studied by electron microscopy. Am J Ophthalmol 82:179-187
42. Shields MB (1998) Optic nerve head and peripapillary retina. Textbook of Glaucoma. Williams & Wilkins, Baltimore, pp 72-107
43. Zhang JJ, Jacob TJ (1996) Volume regulation in the bovine lens and cataract. The involvement of chloride channels. J Clin Invest 97:971-978
44. Chamberlain MC, Kormanik PA (1999) Salvage chemotherapy with tamoxifen for recurrent anaplastic astrocytomas. Arch Neurol 56:703-708
45. Ransom CB, O'Neal JT, Sontheimer H (2001) Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J Neurosci 21:7674-7683
46. Klijn JG, Beex LV, Mauriac L et al (2000) Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study. J Natl Cancer Inst 92:903-911
47. Genazzani AR, Gadducci A, Gambacciani M (2001) Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Climacteric 4:181-193
48. Batur P, Blixen CE, Moore HC et al (2006) Menopausal hormone therapy (HT) in patients with breast cancer. Maturitas 53:123-132
49. Vernon SA, Hawker MJ, Ainsworth G et al (2005) Laser scanning tomography of the optic nerve head in a normal elderly population: the Bridlington Eye Assessment Project. Invest Ophthalmol Vis Sci 46:2823-2828
50. Akar ME, Taskin O, Yucel I et al (2004) The effect of the menstrual cycle on optic nerve head analysis in healthy women. Acta Ophthalmol Scand 82:741-745
51. Gallicchio L, Tkaczuk K, Lord G et al (2004) Medication use, tamoxifen (TAM), and TAM metabolite concentrations in women with breast cancer. Cancer Lett 211:57-67